Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
SEPT9 is a member of the septin family involved in cytokinesis and cell cycle control.
Showing 10 out of 37 products:
Human Polyclonal SEPT9 Primary Antibody pour ELISA, WB - ABIN564709
Tóth, Galamb, Spisák, Wichmann, Sipos, Valcz, Leiszter, Molnár, Tulassay: The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer. dans Pathology oncology research : POR 2011
Cow (Bovine) Polyclonal SEPT9 Primary Antibody pour WB - ABIN2784607
Sudo, Ito, Iwamoto, Morishita, Asano, Nagata: SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling. dans Human mutation 2007
The SEPT9 assay exhibited satisfactory performance in colorectal cancer diagnosis and screening, while more evidence is needed for therapeutic effect monitoring and prognosis prediction.
Studies indicate that methylated Septin 9 ((m)SEPT9) can be consistently detected in plasma samples derived from whole blood samples collected with S-Monovette(R) K3E and BD Vacutainer (R) K2EDTA tubes stored at 2-8 degrees C for a maximum of 24 h and for samples collected in S-Monovette CPDA tubes stored at 18-25 degrees C for up to 48 h.
our study has validated a new SEPT9 assay and combined testing as an aid in cancer detection, providing a new approach for opportunistic CRC (Montrer CALR Anticorps) screening.
Study shows a stepwise increase of SEPT9 methylation from non-cancerous to cancerous tissue in colorectal adenocarcinoma.
Study found SHOX2 (Montrer SHOX2 Anticorps) and SEPT9 frequently methylated in biliary tract cancers.
The first evidence of an interaction between septins and a nonmitotic kinesin is provided and it is suggested that SEPT9 modulates the interactions of KIF17 (Montrer KIF17 Anticorps) with membrane cargo.
SEPT9 promoter methylation and MN frequency, both measured in peripheral blood, occur at an early stage compared to carcinoma development, indicating that the approach might be suitable to monitor CRC (Montrer CALR Anticorps) development.
KRAS mutations and SEPT9 promoter methylation were present in 34% (29/85) and in 82% (70/85) of primary tumor tissue samples.
we demonstrate that SEPT9 negatively regulates EGFR (Montrer EGFR Anticorps) degradation by preventing the association of the ubiquitin ligase Cbl (Montrer CBL Anticorps) with CIN85 (Montrer SH3KBP1 Anticorps), resulting in reduced EGFR (Montrer EGFR Anticorps) ubiquitylation
provide a full overview of the theoretical basis, development, validation, and clinical applications of the SEPT9 assay for both basic science researchers and clinical practitioners
observations suggested that Sept9 contributed to alleviate liver fibrosis might partially through promoting activated HSCs apoptosis and this anti-fibrogenesis effect might be blocked by DNMT (Montrer DNMT1 Anticorps)-3a mediated methylation of Sept9
The altered T-cell homeostasis caused by the loss of Sept9 results in an increase of CD8 (Montrer CD8A Anticorps)(+) central memory T-cells.
SEPT9 gene amplification and overexpression during mouse breast tumorigenesis
Data reveal the importance of Sept9 for septin (Montrer SEPT6 Anticorps) filament formation and general cell stability.
Zebrafish possess two genes, sept9a and sept9b that, like humans, express multiple transcripts.
This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.
, MLL septin-like fusion protein MSF-A
, Ov/Br septin
, ovarian/breast septin
, septin D1
, MLL septin-like fusion
, SL3-3 integration site 1 protein
, eighth septin
, septin-like protein